Sort
64,565 grants matching “drug discovery”
Development of computational and AI/ML tools to accelerate discovery of vaccines and antibodies against nitazenes and fentanyl analogs
$637,128Marco Pravetoni · University Of Washington · R01 · FY2025 · DA
Immunoproteasome inhibitors for the treatment of Alzheimers disease
$637,078Kyung Bo Kim · Florida International University · R01 · FY2023 · AG
UCSD Cancer Center Training Program in Drug Development
$637,071Michael Bouvet · University Of California, San Diego · T32 · FY2022 · CA
Directing fate, subtype identity and survival in human pluripotent-derived midbrain dopamine neurons
$637,063Lorenz P. Studer · Sloan-Kettering Inst Can Research · R01 · FY2022 · NS
Antiviral Lead Identification to Treat Filovirus Infections
$637,035Vincent Jo Davisson · Purdue University · R01 · FY2022 · AI
Genetic Analysis of Toxinogenesis in Vibrio Cholerae
$636,937John J Mekalanos · Harvard Medical School · R01 · FY2012 · AI
Directing Fate, Subtype Identity and Survival in Human Pluripotent-Derived Midbrain Dopamine Neurons
$636,922Lorenz P. Studer · Sloan-Kettering Inst Can Research · R01 · FY2023 · NS
Targeting the stromal niche for tissue-resident lymphocytes in asthma
$636,843Tien Peng · University Of California, San Francisco · R01 · FY2025 · HL
Identification of new inhibitors of essential functions in M. tuberculosis by high-throughput metabolic profiling
$636,812Michael Berney · Albert Einstein College Of Medicine · R01 · FY2024 · AI
Identification of new inhibitors of essential functions in M. tuberculosis by high-throughput metabolic profiling
$636,812Michael Berney · Albert Einstein College Of Medicine · R01 · FY2025 · AI
The hippocampal dentate gyrus in aging and Alzheimer's disease: boosting transcription of retinoic acid-sensitive genes through vitamin A supplementation and HDAC inhibition
$636,809John Joshua Lawrence · Texas Tech University Health Scis Center · R01 · FY2022 · AG
Bronchiolitis Obliterans: Discovery and Therapy
$636,798Corey S Cutler · Dana-Farber Cancer Inst · P01 · FY2024 · HL
MRI-GENetics Interface Exploration_MRI-GENIE_Study
$636,790Natalia S Rost · Massachusetts General Hospital · R01 · FY2017 · NS
MRI-GENetics Interface Exploration_MRI-GENIE_Study
$636,789Natalia S Rost · Massachusetts General Hospital · R01 · FY2018 · NS
MRI-GENetics Interface Exploration_MRI-GENIE_Study
$636,789Natalia S Rost · Massachusetts General Hospital · R01 · FY2019 · NS
Clinical Pharmacology Training Program
$636,774Scott A. Waldman · Thomas Jefferson University · T32 · FY2018 · GM
Dissecting triazole resistance and transcriptional regulation of ergosterol homeo
$636,759Haoping Liu · University Of California-Irvine · R01 · FY2016 · AI
Dissecting triazole resistance and transcriptional regulation of ergosterol homeo
$636,759Haoping Liu · University Of California-Irvine · R01 · FY2015 · AI
Developing Chemical Probes for Inflammatory Pain
$636,751Bahaa Elgendy · St. Louis College Of Pharmacy · R01 · FY2022 · NS
Advancing image-based profiling
$636,740Anne E. Carpenter · Broad Institute, Inc. · R35 · FY2025 · GM
Advancing image-based profiling
$636,740Anne E. Carpenter · Broad Institute, Inc. · R35 · FY2023 · GM
Advancing image-based profiling
$636,740Anne E. Carpenter · Broad Institute, Inc. · R35 · FY2024 · GM
Strategy for combining circulating tumor DNA (ctDNA) and magnetic resonance imaging (MRI) measures of tumor burden for prediction of response and outcome in neoadjuvant-treated early breast cancer
$636,712Laura J Van't Veer · University Of California, San Francisco · R01 · FY2024 · CA
Dissecting the role and mechanism of EML4-ALK condensates in oncogenic signaling and tumor growth
$636,702Trever G Bivona · University Of California, San Francisco · R01 · FY2024 · CA
Incorporating Phase I/II drug/chemical metabolism in HTS via micro scale co-culture
$636,657Jose Antonio Jimenez-Torres · Onexio Biosystems, Llc · R44 · FY2021 · ES